dextroamphetamine has been researched along with MS (Multiple Sclerosis) in 1 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lisdexamfetamine dimesylate (LDX) is a D-amphetamine prodrug currently approved for attention deficit (hyperactivity) disorder with the potential to be better tolerated due to its prolonged clinical effect." | 2.78 | Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study. ( Benedict, RH; Cookfair, D; Morrow, SA; Patrick, K; Smerbeck, A; Weinstock-Guttman, B, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morrow, SA | 1 |
| Smerbeck, A | 1 |
| Patrick, K | 1 |
| Cookfair, D | 1 |
| Weinstock-Guttman, B | 1 |
| Benedict, RH | 1 |
1 trial available for dextroamphetamine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study.
Topics: Adolescent; Adult; Analysis of Variance; Central Nervous System Stimulants; Cognition Disorders; Dex | 2013 |